HCPCS Level II · Procedures and professional services (temporary)
G2157Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About G2157
G2157 is an HCPCS Level II code in the G series (procedures and professional services (temporary)), describing patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period.
It was added to HCPCS effective 01/01/2020, and its current record took effect 01/01/2021.
It was terminated on 12/31/2020 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Pneum vacc 12 mo 60+
- Date added
- 01/01/2020
- Action effective
- 01/01/2021
- Termination date
- 12/31/2020
- BETOS
- Z2
Related G21xx codes
- G2100Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
- G2101Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
- G2105Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period
- G2106Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
- G2107Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
- G2112Patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months
- G2113Patient receiving >5 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity
- G2115Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
- G2116Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
- G2118Patients 81 years of age and older with at least one claim/encounter for frailty during the measurement period
- G2121Depression, anxiety, apathy, and psychosis assessed
- G2122Depression, anxiety, apathy, and psychosis not assessed
Common questions about G2157
Is HCPCS G2157 still valid?
- No. G2157 was terminated on 12/31/2020.
Does Medicare cover G2157?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.